Exponent (NASDAQ:EXPO) Stock Price Down 4% – Should You Sell?

Exponent, Inc. (NASDAQ:EXPO) traded down 4% during trading on Friday . The stock traded as low as $100.76 and last traded at $102.12. 28,659 shares traded hands during trading, a decline of 88% from the average session volume of 245,406 shares. The stock had previously closed at $106.36.

Analyst Upgrades and Downgrades

Separately, Truist Financial restated a “buy” rating and issued a $120.00 target price (up from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Exponent Trading Down 7.0 %

The firm has a 50-day moving average of $109.16 and a 200-day moving average of $99.91. The stock has a market capitalization of $5.01 billion, a price-to-earnings ratio of 50.74 and a beta of 0.66.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, October 24th. The business services provider reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. The firm had revenue of $125.09 million during the quarter, compared to analysts’ expectations of $125.96 million. Exponent had a net margin of 19.35% and a return on equity of 28.39%. On average, equities research analysts anticipate that Exponent, Inc. will post 2.04 EPS for the current year.

Insider Transactions at Exponent

In other Exponent news, VP John Pye sold 3,956 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the sale, the vice president now owns 28,422 shares in the company, valued at approximately $2,984,310. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 2.10% of the company’s stock.

Hedge Funds Weigh In On Exponent

A number of hedge funds have recently bought and sold shares of EXPO. Comerica Bank grew its stake in Exponent by 8.7% in the 1st quarter. Comerica Bank now owns 231,131 shares of the business services provider’s stock valued at $19,112,000 after acquiring an additional 18,429 shares during the period. Silvercrest Asset Management Group LLC grew its stake in Exponent by 6.8% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 276,500 shares of the business services provider’s stock valued at $22,864,000 after acquiring an additional 17,496 shares in the last quarter. SG Americas Securities LLC raised its holdings in Exponent by 601.1% in the 1st quarter. SG Americas Securities LLC now owns 12,866 shares of the business services provider’s stock valued at $1,064,000 after acquiring an additional 11,031 shares during the last quarter. Raymond James & Associates lifted its stake in Exponent by 4.1% in the 2nd quarter. Raymond James & Associates now owns 487,035 shares of the business services provider’s stock worth $46,327,000 after purchasing an additional 19,051 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of Exponent by 5.8% during the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock worth $437,153,000 after purchasing an additional 291,047 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.